Liposomes: From biophysics to the design of peptide vaccines

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 2, 1999, Pages 181-189

  Frezard F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Encapsulation; Immunoadjuvant; Immunostimulant; Liposome; Vaccine

Indexed keywords

IMMUNOLOGICAL ADJUVANT; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL;

BILAYER MEMBRANE; CELL MEMBRANE FLUIDITY; CHEMICAL COMPOSITION; CONFERENCE PAPER; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; ENCAPSULATION; IMMUNE RESPONSE; IMMUNOPOTENTIATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEMBRANE FUSION; MOLECULAR SIZE; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINE PRODUCTION;

EID: 18744438123     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000200006     Document Type: Conference Paper

References (37)

1. Ostro MJ (1987). Introduction. In: Ostro MJ (Editor), Liposomes: from Biophysics to Therapeutics. Marcel Dekker, Inc., New York and Basel.
2. New RRC (1990). Introduction. In: New RRC (Editor), Liposomes - a Practical Approach. IRL Press, Oxford, New York, Tokyo.
3. Allison AC & Gregoriadis G (1974). Liposomes as immunological adjuvants. Nature, 252: 252.
4. Gregoriadis G (1990). Immunological adjuvants: a role for liposomes. Immunology Today, 11: 89-97.
5. Alving CR (1991). Liposomes as carriers of antigens and adjuvants. Journal of Immunological Methods, 140: 1-13.
6. Gregoriadis G (1993). Liposome as immunological adjuvants for peptide and protein antigens. In: Gregoriadis G, Florence AT & Patel AM (Editors), Liposomes in Drug Delivery. Harwood Academic Publishers, Switzerland.
7. Kersten GFA & Crommelin DJA (1995). Liposomes and ISCOMS as vaccine formulations. Biochimica et Biophysics Acta, 1241: 117-138.
8. Gregoriadis G (1995). Engineering liposomes for drug delivery: progress and problems. Trends in Biotechnology, 13: 527-537.
9. Connor J, Yatvin M & Huang L (1984). PH-sensitive liposomes: acid induced fusion. Proceedings of the National Academy of Sciences, USA, 81: 1715-1720.
10. Legendre J-Y & Szoka Jr FC (1995). Liposomes for gene therapy. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France.
11. Crowe JH, Hoekstra FA & Crowe LM (1992). Anhydrobiosis. Annual Review of Physiology, 54: 579-599.
12. Allen TM, Hong K & Papahadjopoulos D (1990). Membrane contact fusion and hexagonal (HII) transitions in phosphatidyl ethanolamine liposomes. Biochemistry, 29: 2976-2985.
13. Gregoriadis G (1993). Liposome Technology. 2nd edn. CRC Press Inc., Boca Raton, FL.
14. Friede M, van Regenmortel MHV & Schuber F (1993). Lyophilized liposomes and shelf items for the preparation of immunogenic liposome-peptide conjugates. Analytical Biochemistry, 211: 117-122.
15. Szoka F & Papahadjopoulos D (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences, USA, 75: 4194-4198.
16. Kirby C & Gregoriadis G (1984). Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology, 2: 979-984.
17. Shew RL & Deamer DW (1985). A novel method for encapsulation of macromolecules in liposomes. Biochimica et Biophysica Acta, 816: 1-8.
18. Tan L, Loyter A & Gregoriadis G (1989). Incorporation of reconstituted influenza virus envelopes into liposomes: studies of the immune response in mice Biochemical Society Transactions, 17: 129-130.
19. Freitas TV & Frézard F (1997). Encapsulation of native crotoxin in liposomes: a safe approach for the production of antivenom and vaccination against Crotalus durissus terrificus venom. Toxicon, 35: 91-100.
20. Frézard F, Toledo VPCP, Elias RM, Tavares CAP, Da Costa CA, Genaro O & Mayrink W (1995). Vaccination of C57BL/ 10 mice against cutaneous leishmaniasis by liposome-encapsulated antigens. Memórias do Instituto Oswaldo Cruz, 90 (Suppl 1): 194 (Abstract IM-091).
21. Brunner J, Skrabal P & Hauser H (1976). Single bilayer vesicles prepared without sonication. Physico-chemical properties. Biochimica et Biophysics Acta, 455: 322-331.
22. + permeability, active doxorubicin encapsulation and stability in human serum. Biochimica et Biophysica Acta, 1194: 61-68.
23. Riess JG, Frézard F, Greiner J, Kraft MP, Santaella C, Vierling P & Zarif L (1995). Membranes, vesicles and other supramolecular systems made from fluorinated amphiphiles. In: Barenholz Y & Lasic D (Editors), Handbook of Non-Medical Applications of Liposomes. CRC Press Inc., Boca Raton, FL.
24. Frézard F, Santaella C, Vierling P & Riess JG (1994). Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. Biochimica et Biophysica Acta, 1192: 61-70.
25. Fattal E, Ramaldes GA & Ollivon M (1995). Oral delivery of vaccines by means of liposomes. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications Editions de Santé, France.
26. Crowe LM, Crowe JH, Rodolph A, Womersley C & Appel L (1985). Preservation of freeze-dried liposomes by trehalose. Archives of Biochemistry and Biophysics, 242: 240-247.
27. Crowe LM & Crowe JH (1995). Freeze-dried liposomes. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France.
28. Devine DV & Marjan JMJ (1997). The role of immuno-proteins in the survival of liposomes in the circulation. Critical Reviews in Therapeutic Drug Carrier Systems, 14: 105-131.
29. Liu F & Liu D (1996). Serum independent liposome uptake by mouse liver. Biochimica et Biophysica Acta, 1278: 5-11.
30. Oussoren C, Zuidema J, Crommelin DJ & Storm G (1997). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochimica et Biophysica Acta, 1328: 261-272.
31. Lasic DD & Papahadjopoulos D (1995). Liposomes revisited. Science, 267: 1275-1276.
32. Santaella C. Frézard F, Vierling P & Riess JG (1993). Extended in vivo blood circulation time of fluorinated liposomes. Federation of European Biochemical Societies Letters, 336: 481-484.
33. Gupta RK, Varanelli CL, Griffin P, Wallach DF & Sibber GR (1997). Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. Vaccine, 14: 219-225.
34. Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, Fujiwara H, Hamaoka T & Mayumi T (1997). Positively charged liposomes function as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochemical and Biophysical Research Communications, 240: 793-797.
35. Reddy R. Zhou F, Nair S. Huang L & Rouse BT (1992). In vivo cytotoxic T lymphocytes induction with soluble proteins administered in liposomes. Journal of Immunology, 148: 1585-1589.
36. Cohen S & Langer R (1995). Long-term protein delivery from microencapsulated liposome systems. In: Puisieux F. Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France.
37. Gregoriadis G (1998). Genetic vaccines: strategies for optimization. Pharmaceutical Research, 15: 661-670.